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Background
22q11.2 deletion syndrome (22q11.2DS) is associated with high
rates of neurodevelopmental disorder, however, the links
between developmental coordination disorder (DCD), intellec-
tual function and psychiatric disorder remain unexplored.
Aims
To establish the prevalence of indicative DCD in children with
22q11.2DS and examine associations with IQ, neurocognition
and psychopathology.
Method
Neurocognitive assessments and psychiatric interviews of 70
children with 22q11.2DS (mean age 11.2, s.d. = 2.2) and 32 con-
trol siblings (mean age 11.5, s.d. = 2.1) were carried out in their
homes. Nine children with 22q11.2DS and indicative DCD were
subsequently assessed in an occupational therapy clinic.
Results
Indicative DCD was found in 57 (81.4%) children with 22q11.2DS
compared with 2 (6.3%) control siblings (odds ratio (OR) = 36.7,
P < 0.001). Eight of nine (89%) children with indicative DCD met
DSM-5 criteria for DCD. Poorer coordination was associated with
increased numbers of anxiety, (P < 0.001), attention-deficit
hyperactivity disorder (ADHD) (P < 0.001) and autism-spectrum
disorder (ASD) symptoms (P < 0.001) in children with 22q11.2DS.
Furthermore, 100% of children with 22q11.2DS and ADHD had
indicative DCD (20 of 20), as did 90% of children with anxiety
disorder (17 of 19) and 96% of children who screened positive for
ASD (22 of 23). The Developmental Coordination Disorder
Questionnaire score was related to sustained attention
(P = 0.006), even after history of epileptic fits (P = 0.006) and heart
problems (P = 0.009) was taken into account.
Conclusions
Clinicians should be aware of the high risk of coordination diffi-
culties in children with 22q11.2DS and its association with risk of
mental disorder and specific neurocognitive deficits.
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Motor coordination problems can seriously affect a child’s life,
including activities of daily living (e.g. eating, dressing, grooming),
self-esteem, pastime activities, social relationships and academic
attainment.1 Motor dysfunction can furthermore compound risk
for psychopathology,2 even into adulthood.3 Developmental coord-
ination disorder (DCD) is a neurodevelopmental disorder charac-
terised by motor function that is markedly deficient given the
person’s chronological age and measured intelligence, that is not
explained by any overt motor or sensory deficit.4 DCD is often
comorbid with other neurodevelopmental disorders, particularly
attention-deficit hyperactivity disorder (ADHD), but also anxiety
disorders and autism-spectrum disorder (ASD).2,5–7 For example,
up to 50% of children with DCD have been reported to have a diag-
nosis of ADHD, primarily of the inattentive subtype.8 DCD is also
associated with neurocognitive deficits, including in executive func-
tioning.9 The relationship between IQ and DCD has not been rigor-
ously tested as, because of the current definition, most studies of
DCD have excluded individuals with an IQ in the borderline or
intellectual disability range. However, a better understanding of
the presence of motor dysfunction in children with intellectual dis-
ability can pave the way towards suitable interventions and can also
shed light on possible shared underlying processes.
A diagnosis of DCD is established through a series of multiple
assessments that establish coordination and the impact of difficulties
ondaily life. Screening tools, such as theDevelopmental Coordination
Disorder Questionnaire (DCDQ), can be used effectively in large
populations, and have been shown to have good agreement with
more detailed movement assessments in populations with attention
difficulties, intellectual difficulties or healthy children.10,11 However,
there are no studies comparing the validity of the DCDQ as a
measure of coordination in populations with chromosomal disorders.
22q11.2 deletion syndrome (22q11.2DS) is a rare chromosomal
disorder that affects ≈1 in 2000–4000 live births and is caused by a
hemizygous microdeletion on the long arm of chromosome 22.12 In
childhood, the deletion is associated with high rates of ADHD,
ASD, anxiety disorders and oppositional defiant disorder.13,14
22q11.2DS is also one of the strongest known biological risk factors
for the development of schizophrenia, with about 25% of adult
patients with 22q11.2DS affected.15Mild ormoderate intellectual dis-
ability is common, with reports that the mean IQ of patients with
22q11.2DS is approximately 30 points lower than that of unaffected
siblings.13,14 Coordination problems are increasingly recognised as a
feature of 22q11.2DS, particularly problems with balance, bimanual
coordination and visuomotor skills, that may be independent of
IQ.16–20 Moreover, 22q11.2DS is associated with a number of
factors that have been associated with motor problems such as
preterm birth, hypotonia, seizures and abnormalities of the central
nervous system.21 We are not aware of studies that have investigated
the prevalence of DCD, or of a clear pathway to assigning a diagnosis
of DCD in this population. Furthermore, there are no papers on the
links between coordination problems and IQ and other neurocogni-
tive function or psychopathology in carriers of this deletion. It may
be the case that DCDmay index a greater overall neurodevelopmental
difficulty, and therefore be related to other psychopathology.
We set out to address these gaps in the literature. Our first aim
was to investigate the prevalence of indicative DCD in children with
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22q11.2DS in comparison with siblings without the deletion by
screening for DCD using the DCDQ. Our second aim was to evalu-
ate the degree to which the DCDQ captured the motor performance
difficulties associated with DCD in this population. This was
achieved by conducting the gold-standard Movement Assessment
Battery for Children-2 (MABC-2)22 in an occupational therapy
clinic in a subset of nine of the children with indicative DCD, to
ensure that the DCDQ is accurately reflecting coordination difficul-
ties in this population. Third, we investigated the relationships
between indicative DCD and psychiatric problems that are
common in children with 22q11.2DS (ADHD, ASD and anxiety dis-
order). Fourth, we aimed to explore the relationship between indi-
cative DCD and IQ and specific neurocognitive functions in this
population. We hypothesised that there would be a high incidence
of indicative DCD in children with 22q11.2DS and that most of
the children who screened positive would meet diagnostic criteria
for DCD; and furthermore, that indicative DCDwould be associated
with risk of ADHD, ASD and anxiety disorder, as well as poorer
cognitive ability. Finally, we also explored whether specific
medical aspects of 22q11.2DS (preterm birth, history of heart pro-
blems and epileptic fits) contributed to risk of indicative DCD
and possible links with psychopathology and cognition.
Method
Participants
Participants were members of the ongoing Experiences of CHildren
with cOpy number variants (ECHO) study. Children with
22q11.2DS were recruited through medical genetics clinics across
the UK, charities for chromosomal conditions as well as
22q11.2DS specifically (Unique, 22Crew and MaxAppeal!) and
word of mouth. Unaffected siblings closest in age to the child with
the deletion were also invited to take part. Inclusion criteria were
age 6 years of age or older (in order for the psychiatric assessment
to be valid) and for the child with the deletion, confirmation of
22q11.2DS by Medical Genetics laboratories, using standard
methods (fluorescence in situ hybridisation/microarray) and subse-
quently in the laboratory of the MRC Centre for Neuropsychiatric
Genetics andGenomics at Cardiff University, usingmicroarray tech-
niques. The current study was based on 70 children with 22q11.2DS
(58.6% male, mean age 11.2 years, s.d. = 2.2) and 32 unaffected sib-
lings (43.8% male, mean age 11.5, s.d. = 2.1). Children with
22q11.2DS did not differ in age (P = 0.50) or gender distribution
(P = 0.16) from the control siblings. Informed and written consent
was obtained prior to recruitment from the carers of the children
and recruitment was carried out in agreement with protocols
approved by the appropriate research and National Health Service
ethics and research and development committees. The primary
carers of the children provided information on the children’s phys-
ical health. Ten children (14.2%) with 22q11.2DS were born earlier
than 37 weeks, 12 (17.1%) had a history of epileptic fits, 34
(48.6%) of a heart problem and 2 (2.9%) of low calcium levels in
early childhood. None of the children were receiving medication
for ADHD and one child was taking sodium valproate for epilepsy,
along with fluoxetine and risperidone for a psychotic disorder.
Coordination assessment (DCDQ/MABC-2)
The DCDQ23 was completed by the primary carer. It is designed to
screen for motor coordination impairments in children 5–15 years
old and is well validated.10 DCDQ scores range from 15 to 75,
with discrimination thresholds that are dependent on age. In
general, lower scores indicate greater coordination problems. The
DCDQ assesses coordination either while moving or when using
the hands. It yields a total score as well as separate scores for three
subscales: control during movement, fine motor/handwriting and
general coordination scores. Participants were categorised into
those with and without indicative DCD based on DCDQ total
score compared with the appropriate age threshold.
TheDCDQcanbe used to indicatewhether a child is likely tohave
DCD, although additional assessments are necessary to establish the
diagnosis. The DCDQ is useful in establishing functional difficulties
in everyday life because of coordination impairment, but reliable
and valid motor assessments are required to accurately assess if
motor performance is substantially below the level expected given
the child’s chronological age and/or IQ. To establish the extent to
which the DCDQ captures DCD in this population, a subsample of
nine children with 22q11.2DS (mean age 12.05, s.d. = 2.56, 6 (67%)
male) who screened positive on the DCDQ were assessed by trained
and experienced occupational therapists using the MABC-2.22 As
the ECHO study recruits children with 22q11.2DS from all over the
UK, not all families are able to travel to Cardiff for assessments.
Therefore, these nine families were selected based on proximity to
Cardiff University. Using the MABC-2, we obtained an overall
score, and scores for the three subdomains: manual dexterity,
aiming/catching and balance. Scores on the MABC-2 below the fifth
percentile generally indicate severe problemswithmotor coordination
that require intervention. Information from the MABC-2, and previ-
ously collected assessments were used to establish a research diagnosis
of DCD based on DSM-5 criteria.24
Parents also completed questions on three developmental mile-
stones: age at which the child learned to ride a bike, do up their shoe-
laces and fasten buttons. These milestones give a general measure of
gross and fine motor skill development, complementing other infor-
mation. Sample sizes for milestone comparisons differ as only a pro-
portion of participants had attained the milestones at the time of
data collection.
IQ assessment
Full-scale, verbal and performance IQ was obtained by administer-
ing the Wechsler Abbreviated Scale of Intelligence (WASI).25
Cognitive function assessment
Cognitive function was assessed using tasks that are relevant for risk
of psychopathology. Processing speed (five- choice reaction
time task), sustained attention (rapid visual processing task),
spatial working memory (SWM), spatial planning (stockings of
Cambridge) and visual attention (match to sample task) were
assessed using the Cambridge Neuropsychological Test Automated
Battery (CANTAB).26 Furthermore, the Wisconsin Card Sorting
Test 32 (WCST)27 was also administered, where the number of
perseverative errors measures the set shifting ability of executive
function. Non-perseverative errors are also reported. All neurocog-
nitive measures were standardised to have a mean of zero and a
standard deviation of one, with the exception of IQ.
Psychopathology assessment
The Social Communication Questionnaire (SCQ),28 was used to
screen for ASD symptoms. Total scores can range from 0 to 39,
and a score of 15 or greater is suggestive of putative ASD. The
SCQ yields a total score and three subscale scores (behaviour,
social and communication). The behaviour subscale measures
repetitive and stereotyped behaviours, the social scale probes
aspects of reciprocal social interaction such as eye gaze and social
smiling, and the communication subscale asks about communica-
tion ability including social chat and gestures.
The semi-structured Child and Adolescent Psychiatric
Assessment interview (CAPA)29 was conducted by trained
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psychologists with the primary caregiver and children themselves
where possible and appropriate. Interviews were audiotaped and
DSM-5 diagnosis obtained during consensus meetings lead by a
child and adolescent psychiatrist. We did not consider diagnoses
to be mutually exclusive. Other psychiatric diagnoses and symp-
toms were obtained from the CAPA. A symptom was counted as
present if the individual had scored a two or three on the relevant
CAPA question. Anxiety symptoms included any symptom of gen-
eralised anxiety disorder, social phobia, specific phobia, separation
anxiety, panic disorder with and without agoraphobia, agoraphobia
and obsessive-compulsive disorder. An individual with a research
diagnosis of one of these anxiety disorders was classified as
having ‘any anxiety disorder’.
All assessments were carried out as part of the ongoing ECHO
study, either in participants’ homes or during visits to our labora-
tory at Cardiff University. Sample sizes for analyses using the IQ,
cognitive and symptom data differ, as complete data-sets were not
available for some participants, because of the individuals having
difficulties in completing measures.
Statistical analysis
Statistical analysis was carried out in R version 3.3.3 (https://www.R-
project.org/). Differences in group statistics scores between the
22q11.2DS and sibling groups were established using t-tests or
Wilcoxon tests where appropriate with respect to normality. DCD
and mental disorder prevalence in children with 22q11.2DS com-
pared with control siblings was examined using a chi-squared test.
Spearman correlations were used to assess associations between
the DCDQ total score and age of attaining milestones. Pearson
correlation was used to test association between indicative DCD
and MABC-2 score. Associations between psychiatric symptoms
(ADHD, SCQ score, any anxiety disorder), IQ and neurocognitive
measures and indicative DCD were established using linear regres-
sion. Predictors were entered hierarchically, age first, then gender
and finally the psychopathology, cognition or IQ variable.
Sensitivity analyses were carried out to investigate whether
comorbid factors (preterm birth, history of epileptic fits or heart
problems) contributed to our findings. We calculated rates of
indicative DCD excluding the children with either preterm birth,
or epileptic fits or heart problems. Furthermore, we repeated the
regression analyses including these conditions as covariates one at
a time. As levels of medication use (1.4%, 1/70) and history of hypo-
calcaemia (2.8%, 2/70) were low, these were not taken into consid-
eration in these analyses.
Results
Descriptive statistics about the families are presented in Table 1.
Prevalence of indicative DCD in 22q11.2DS
Childrenwith 22q11.2DS had lower scores on theDCDQ(22q11.2DS
group median 39.5; controls median 73.5, P < 0.001) and all subscales
(control during movement P < 0.001, fine motor P < 0.001, general
coordination P < 0.001), reflecting poorer coordination. In total 57
children with 22q11.2DS met criteria for indicative DCD (81.4%)
compared with two control siblings (6.3%) (χ2 = 50.9, P < 0.001,
odds ratio (OR) = 36.7). Similar numbers of males and females (n =
36, 87.8% ofmales, n = 21, 72.4% of females) with 22q11.2DSmet cri-
teria for indicative DCD (χ2 = 2.66, P = 0.103, OR = 2.05).Males had a
median score of 36 on the DCDQ v. 45 in females (P = 0.013).
Children with 22q11.2DS had a higher mean age of learning to
ride a bike and do up buttons compared with control siblings (dif-
ference of 14.26 months for learning to ride a bike; 22.21 months for
doing up buttons, Table 2). Developmental coordination problems
correlated with age of attainment of doing up buttons (r =−0.51, P
< 0.001); but not tying shoelaces (r =−0.43, P = 0.060) or riding a
bike (r =−0.27, P = 0.086); whereas no associations were found
for the siblings.
Of the nine children with 22q11.2DS assessed with the MABC-2
eight had overall scores below the fifth percentile. Of the nine, three
had scores below the fifth percentile on the aiming/catching domain,
four had scores below the fifth percentile in the manual dexterity
domain and five had scores below the fifth percentile in the
balance domain. Performance on the individual domains was vari-
able, however, children did not always score below the fifth percent-
ile in all domains, rather, they frequently performedmarkedly poorly
in one or two domains and slightly better in the third domain. Of the
eight children who had overall scores below the fifth percentile, three
scored below the fifth percentile in one domain, three in two
domains and one in three domains. DCDQ total score was not asso-
ciated with MABC-2 overall standard score, (r = 0.63, P = 0.070).
Associations between indicative DCD and
psychopathology
In total, 32.9% (23/70) of children with 22q11.2DS met criteria for
ADHD, compared with 3.3% (1/30) of siblings; 29.0% (20/69) of
children with 22q11.2DS met criteria for any anxiety disorder,
Table 1 Descriptive statistics of sample
Characteristics Variable n χ2 (P)
Mother’s ethnic background, n
(%)
75
European 69 (92.0)
Mixed 5 (6.7)
Unknown 1 (1.3)
Inheritance, n (%) 70
De novo 58 (82.9)
Inherited 6 (8.6)
Unknown 6 (8.6)
Highest maternal qualification, n
(%)
75
High (university degree and/or
other higher postgraduate
qualification)
18 (24.0)
Middle (A-levels/highers/
vocational training)
34 (45.3)
Low (O-levels/GCSEs) 15 (20.0)
No school leaving exams 8 (10.7)
Family Income, n (%) 75
≤£19 999 19 (25.3)
£20 000 - £39 999 22 (29.3)
£40 000 - £59 999 16 (21.3)
≥£60 000 15 (20.0)
Unknown 3 (4.0)
Age, years: mean (s.d.) range
Probands 70
Male 11.10 (2.20) 6.20–14.87
Female 11.58 (2.31) 7.11–14.75
Siblings 32
Male 11.75 (1.58) 9.24–14.89
Female 11.39 (2.40) 6.18–14.88
Gender, n (%) 1.940
(0.163)
Probands 70
Male 41 (58.6)
Female 29 (41.4)
Siblings 32
Males 14 (43.8)
Female 18 (56.3)
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compared with 6.7% (2/30) of siblings and 34.3% (23/67) of children
with 22q11.2DS screened positive for putative ASD whereas no sib-
lings did (0/32). Similarly, the rates of ADHD, putative ASD and
anxiety symptoms were higher in children with 22q11.2DS than sib-
lings (Table 2).
Of the children with indicative DCD and complete diagnosis
data for ASD, ADHD and anxiety, 69.8% (37/53) had at least one
psychiatric disorder compared with 15.4% (2/13) of individuals
without indicative DCD (P < 0.001, OR = 5.84). Fig. 1 shows the
high rate of co-occurrence between motor dysfunction and psycho-
pathology. In total, 30.2% (16/53) of individuals with indicative DCD
met criteria for at least two, and 11.3% (6/53) for all three disorders.
Of children with 22q11.2DS and indicative DCD, 38% (20/53) met
the criteria for ADHD, compared with 0% (0/13) of children
without indicative DCD (P = 0.008, OR = 3.47). Percentages for
putative ASD were 41.5% (22/53) v. 7.7% (1/13) (P = 0.022, OR =
2.46) and for anxiety disorder 32.1% (17/53) v. 15.4% (2/13) (P =
0.234, OR = 1.7) in children with and without indicative DCD,
respectively. All (100%, 20/20) children with ADHD had indicative
DCD, as did 89.5% (17/19) of children with any anxiety disorder and
95.7% (22/23) of children with putative ASD.
The DCDQ total score was associated with ADHD symptom
count (P < 0.001), but not age (P = 0.497) or gender (P = 0.374)
and this association was driven by inattentive (P < 0.001) but not
hyperactivity symptoms (P = 0.051). Scores on all three subscales
of the DCDQ were associated with ADHD symptoms (fine motor
skill P < 0.001, control during movement P < 0.001, general coordin-
ation P < 0.001).
DCDQ total score was also associated with putative ASD score
(P < 0.001), but not age (P = 0.304) or gender (P = 0.188). The
control during movement (P < 0.001), general coordination (P =
0.003), as well as fine motor (P < 0.001) subscales were all associated
with putative ASD score. Further analysis showed that all three subt-
ests of the putative ASD score (behaviour P < 0.001, communication
P < 0.001, social P = 0.026) predicted DCDQ total score.
DCDQ total score was furthermore associated with anxiety
symptoms (P < 0.001), along with gender (P = 0.041), with boys
having lower DCDQ scores, but not age (P = 0.341). Scores on the
fine motor skill subscale were associated with anxiety symptoms
(P = 0.004) and gender (P = 0.005). The scores on the general
Table 2 Results of group comparisons
Measure
22q11.2
DS group
Control
siblings
Total,a n
χ2 OR t z
95% CI for
differences in
means/medians P
22q11.2
DS group
Control
siblings
Indicative developmental coordination
disorder, n
70 32 50.9 36.7 <0.001
Positive 57 2
Negative 13 30
Age motor milestones achieved,
months:a mean (s.d.)
Learned to ride a bike 75.88 (20.45) 61.62 (18.66) 40 27 2.95 (4.58 to 23.91) 0.005
Learned to do up buttons 72.21 (24.74) 50.00 (14.83) 48 25 4.78 (12.95 to 31.47) <0.001
Learned to tie shoelaces 95.45 (29.97) 82.17 (22.7) 20 24 1.63 (−3.26 to 29.83) 0.112
Psychopathology, median (IQR)
Attention–deficit hyperactivity disorder,
symptom count
5 (7.75) 0 (0.00) 70 30 5.87 (3 to 7) <0.001
Putative autism-spectrum disorder score 11 (11.00) 1 (2.00) 67 32 6.94 (7 to 12) <0.001
Anxiety symptoms 3 (9.75) 0 (1.00) 66 29 3.79 (1 to 3) <0.001
IQ, mean (s.d.)
Full-scale IQ 70.75 (11.94) 104.58 (15.71) 70 31 −10.65 (−40.22 to −27.44) <0.001
Performance IQ 74.55 (12.87) 102.68 (17.46) 67 31 −8.02 (−35.19 to −21.06) <0.001
Verbal IQ 70.97 (12.73) 105.58 (15.68) 68 31 −10.78 (−41.07 to −28.15) <0.001
Cognitive processing,b mean (s.d.)
Processing speed (five-choice reaction time) −0.18 (1.16) 0.36 (0.38) 61 31 −3.30 (−0.86 to −0.21) 0.001
Sustained attention (rapid visual processing) −0.26 (1.10) 0.47 (0.56) 55 30 −4.04 (−1.08 to −0.37) <0.001
Visual attention (match to sample) −0.23 (1.03) 0.45 (0.61) 60 31 −3.81 (−1.03 to −0.32) <0.001
Spatial planning −0.27 (0.99) 0.52 (0.81) 57 29 −3.96 (−1.19 to −0.39) <0.001
Spatial working memory −0.34 (0.92) 0.72 (0.77) 67 31 −5.96 (−1.41 to −0.71) <0.001
Set shifting ability 0.06 (0.82) −0.13 (1.32) 66 30 0.76 (−0.33 to 0.73) 0.450
Errors on the Wisconsin Card Sorting Task −0.32 (0.99) 0.70 (0.60) 66 30 −6.25 (−1.34 to −0.70) <0.001
22q11.2 DS, 22q11.2 deletion syndrome; IQR, interquartile range.
a. Total n given for age motor milestone achieved is those who had achieve this milestone at the time of data collection.
b. For spatial planning: stockings of Cambridge – problems solved inminimummoves; set shifting ability: perseverative errors on theWisconsin Card Sorting Task (WCST); errors on theWCST:
non-perseverative errors.
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Fig. 1 Comorbidity in the participants with 22q11.2 deletion
syndrome.
ASD, autism-spectrum disorder; ADHD, attention-deficit hyperactivity disorder; DCD,
developmental coordination disorder.
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coordination subscale were also associated with anxiety symptoms
(P = 0.001) and gender (P = 0.033). Anxiety symptoms (P = 0.004)
but not gender predicted the control during movement score.
Association between indicative DCD and IQ
Mean full-scale IQ of the siblings was higher than in children with
22q11.2DS (Table 2). Of the children with 22q11.2DS with data
for full data for IQ (n = 67), 4 (5.97%) had moderate intellectual dis-
ability (IQ < 55), 29 (43.3%) mild intellectual disability (IQ 55–70),
24 (35.8%) had an IQ in the borderline range (71–85) and 10
(14.9%) an average IQ (86–115). This is in comparison with one
(3.1%) sibling with mild intellectual disability. Indicative DCD was
associated with full-scale IQ in children with 22q11.2DS (P = 0.038).
Relationships between indicative DCD and cognitive
tasks
Children with 22q11.2DS performed more poorly than siblings on
the processing speed, sustained attention, visual attention, spatial
planning and executive functioning tasks (Table 2). In children
with 22q11.2DS, DCDQ score was not related to set shifting
ability (perseverative errors P = 0.444), or total errors (non-perse-
verative errors P = 0.449) on the WCST, nor the processing speed
(reaction time P = 0.424), spatial planning (problems solved in
minimum moves P = 0.765), and SWM (number of errors, P =
0.733) tasks of the CANTAB. However, an association was found
with poorer performance on visual (P = 0.038) as well as sustained
attention (P = 0.006).
Sensitivity analysis of comorbid medical aspects
Excluding children with 22q11.2DS with preterm birth, a history of
heart problems, or epileptic fits did not affect the rates of indicated
DCD, nor any of the links between the DCDQ and psychiatric
disorder. However, with regards to neurocognitive function, includ-
ing epileptic fits or heart problems as a covariate in the analysis
reduced the associations between DCDQ score and both full-scale
IQ (P = 0.056 or P = 0.062, respectively) as well as visual attention
(P = 0.062 and P = 0.055, respectively), but not sustained attention
(P = 0.006 and P = 0.009, respectively). Preterm birth did not affect
the associations between DCDQ score and the neurocognitive
measures.
Discussion
DCD prevalence
The findings indicate that serious motor coordination problems are
common in 22q11.2DS, with over 80% of our sample of deletion car-
riers meeting criteria for indicative DCD. Furthermore, indicative
DCD indexed risk of ADHD, ASD and anxiety disorder as well as
poorer sustained attention. The prevalence of indicative DCD in
our sample differed between males and females with 22q11.2DS,
conforming to the pattern of the male preponderance reported in
the general population.30 This contrasts with other disorders such
as ADHD, where the prevalence seems to be equal between the
genders in 22q11.2DS.14 DCDQ total score was correlated with
age of attainment of developmental milestones providing further
support for the validity of the DCDQ in this population.
Furthermore, 88.9% of children (eight of nine) who had diagnostic
assessments in the occupational therapy clinic, using the gold-
standard MABC-2, met criteria for DCD. This provides additional
support for using the DCDQ as a proxy measure of developmental
coordination dysfunction. Scores on the MABC-2 below the fifth
percentile generally indicate problems with motor coordination
that require intervention. However, performance on individual
domains of the MABC-2 was variable, with no single domain emer-
ging as consistently affected. As such, this evidence suggests that
much like the psychiatric and cognitive phenotype in 22q11.2DS,
there is also considerable variability in the motor phenotype.
Psychopathology
The majority of children with indicative DCD (70%) were found to
have at least one psychiatric disorder, including high rates of
ADHD, anxiety disorder and ASD symptoms. Indicative DCD
was found to be related to ADHD, with children with more inatten-
tive symptoms having greater difficulties with motor coordination.
Studies in children with ADHD not selected for the presence of a
copy number variant have indicated they are more likely to have
impairments in both gross and fine motor skills, particularly if the
child has ADHD of the inattentive subtype. Our previously pub-
lished work comparing children with ADHD with and without
22q11.2DS has found that the deletion is associated with a consid-
erably higher rate of the inattentive subtype as well as a lower rate
of hyperactive-impulsive symptoms. We have suggested this may
contribute to underdiagnosis of ADHD in children with the dele-
tion.31 We also found that children with 22q11.2DS and higher
numbers of ASD symptoms had poorer coordination, a finding
that is similar to studies of children with DCD not selected for a
chromosomal disorder.32 Our finding that children with indicative
DCD had higher levels of anxiety symptoms is in line with other
research showing links between anxiety and DCD.2 Excessive
worry is a well-documented phenomenon in 22q11.2DS,13,14
however, it is not clear whether anxiety and DCD share biological
pathways, or whether DCD contributes to anxiety as a result of
worries about performance. Such worries may particularly affect
children in social settings, for fear of humiliation and social exclu-
sion.2 Future longitudinal studies investigating the developmental
links between motor function and psychopathology can contribute
to better understanding of these issues.
DCD and IQ and other neurocognitive functions
Indicative DCD was related to IQ in children with 22q11.2DS. This
suggests that the observed coordination difficulties seen in this
population can be partially explained by a general deficit in IQ.
This agrees with studies of children with DCD not selected for
having a chromosomal disorder9 and suggests that within an intel-
lectually disabled population, level of impairment is associated with
motor dysfunction. This is in contrast to previous reports by our
group on IQ and psychopathology in children with 22q11.2DS,13
where we found no association.
Indicative DCD was also related to visual attention ability as
measured by the match to sample task and sustained attention as
measured by the rapid visual processing task of the CANTAB.
Together with the here reported association between motor coord-
ination difficulties and the inattentive subtype of ADHD, this sug-
gests common processes underlying coordination and attention.
However, it is unclear if coordination is impaired as a result of an
inability to direct attention appropriately, or if the same brain pro-
cesses are required for good coordination and attention.
The associations between DCDQ score and visual attention were
reduced, however, when epileptic fits or a history of heart problems
were included in the analysis as covariates. This indicates that other
medical aspects associated with 22q11.2DS can contribute to specific
interrelationships and underlines the complex aetiology of the condi-
tion. The link between sustained attention and the DCDQ remained,
however, unchanged by these medical aspects. Impairments in sus-
tained attention33 as well as motor coordination34 have previously
been reported in schizophrenia. The current sample is too young
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to investigate the links with schizophrenia risk; however, this repre-
sents an interesting avenue for future research.
Strengths and limitations
To our knowledge, this is the first study to examine the prevalence of
DCD and its relationship with IQ, and other neurocognition and
neurodevelopmental symptoms in 22q11.2DS. The relatively large
sample and availability of sibling controls for comparisons are add-
itional strengths. Also, the availability of medical information
allowed us to conduct sensitivity analysis and show that the high
rates of indicated DCD could not be explained by preterm birth, a
history of epileptic fits or heart problems. A limitation was the
small subset of individuals evaluated using the MABC-2.
As most coordination and psychopathology data was collected
through home visits a full neurological assessment was not possible,
therefore we cannot rule out other contributing conditions such as
hyper-/hypotonia that can affect coordination. Finally, both the
DCDQ and MABC-2 are measures of overall coordination, and
do not allow insights into underlying sensorimotor and visual infor-
mation processing deficits.
Theoretical implications
The high rate of indicative DCD in 22q11.2DS is a novel finding and
our occupational therapy assessments in a subsample indicate that
the majority of children who screen positive do meet diagnostic cri-
teria for DCD. The presence of coordination deficits raises the ques-
tion of the changes in neural substrates that result from 22q11.2
deletion. The coordination deficits may be because of disruption
of the cerebellum, which has been implicated in both motor and
cognitive syndromes,35 and shows consistent abnormalities in
22q11.2DS.36,37 Cerebellar dysfunction has also been repeatedly
observed in neurodevelopmental disorders, including ASD and
ADHD. Other biological mechanisms that could be involved
include striatal dysfunction, as increased volume of the striatum38–40
and calcification of the basal ganglia40,41 have been observed in
22q11.2DS. In addition, the 22q11.2 deletion is associated with
early-onset Parkinsonism.42,43 The high comorbidity between
anxiety disorder, ADHD and ASD may also point towards
common neural disruptions. The precise origin of the coordination
impairments is not yet known and it is unclear whether motor coord-
ination problems are a common feature of other copy number variant
disorders (for example, duplication of 22q11.2, or deletion/duplica-
tion of 1q21.1 or 16p11.2). More generally, coordination difficulties
may index a general neurodevelopmental impairment in frontostria-
tal and related circuitry that may reflect risk of other psychopathol-
ogies. Future studies should use detailed assessment of fundamental
motor control processes, using kinematic assessment, for example.
This would allow investigation of deficits of these fundamental pro-
cesses and may help identify a cause of coordination difficulties.
Clinical implications
The immediate clinical implication of our findings is that there
should be an increased vigilance for motor impairments in children
with 22q11.2DS so that appropriate support measures can be intro-
duced as early as possible. In addition, DCD is not usually diagnosed
or considered in those with intellectual disability, as themotor deficit
must be demonstrated to be in excess of what would be expected for a
given IQ, but our findings indicate that the majority of children in
this study are affected by potentially serious motor problems. A
formal diagnosis of DCD may facilitate access to appropriate
support and interventions.
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